Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 200.79

-0.2%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Machaon who wrote (20526)	5/11/1998 9:43:00 PM
From: bob zagorin	Read Replies (1) of 32384

someone asked why jim mccamant didn't mention lgnd on cnbc. don't know but here is his rec. on lgnd as of 3/98 as cited on henry's web site. "Ligand is now filing for FDA approval of its first product, a treatment for KS, and THREE MORE DRUGS WILL BE FILED FOR APPROVAL in the next two years. In all, Ligand has more than 30 products in development, some of which target multibillion-dollar markets. Ligand also has seven attractive partnerships; the latest is a $174 million blockbuster deal with Lilly for treating metabolic diseases. Add it all together and the company is well positioned to be one of the few profitable biotechs in 1999." McCamant recommends buying up to $16.00." btw, i'm so happy to see the board focused on dissecting the news and science. this is what made this thread so great before.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next